UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Network Support

Our faculty members hold leadership roles in a variety of research networks, which provide the majority of our study support including funding and research agendas.  We conduct studies in conjunction with these networks to maximize the scope of our clinical research.

AIDS Clinical Trials Group (ACTG)
The ACTG, one of the largest HIV clinical trials organizations in the world, plays a major role in setting standards of care for HIV infection and opportunistic diseases related to HIV/AIDS in the United States and the developed world. The ACTG is comprised of and directed by leading clinical scientists in HIV/AIDS therapeutic research. The ACTG is funded by the Department of Health and Human Services, National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID).

AIDS Malignancy Consortium (AMC)
The AMC is a National Cancer Institute-supported clinical trials group founded in 1995 to support innovative trials for AIDS-related cancers.  Comprised of expert scientists, the AMC working groups deal mostly with the cancers that affect HIV-positive patients-Kaposi's Sarcoma, Lymphoma, Human Papillomavirus-related Cancers (for example, anal and cervical cancers), and Non-AIDS Defining Cancers (for example, lung cancer, head and neck cancer, liver cancer).


HIV Prevention Trials Network (HPTN)
The HPTN is a global collaborative clinical trials network that develops and tests the safety and efficacy of primarily non-vaccine interventions designed to prevent the acquisition and transmission of HIV. The HPTN carries out its mission through a strong network of expert scientists and investigators from both international and U.S. institutions and partnered with a leadership group comprised of three U.S.-based institutions. The HPTN research agenda is focused primarily on the use of antiretroviral therapy for HIV Prevention; treatment and prevention of sexually transmitted infections; treatment of substance abuse, particularly injection drug use; behavioral risk reduction interventions; and structural interventions to reduce HIV transmission and acquisition.


HIV Vaccine Trials Network (HVTN)
The HVTN is an international collaboration of scientists and educators searching for an effective and safe HIV vaccine. The HVTN's mission is to facilitate the process of testing preventive vaccines against HIV/AIDS through the conduct of all phases of clinical trials, the evaluation of experimental vaccines for safety and the ability to stimulate immune responses, the testing of vaccine efficacy.
 
Network for AIDS Research in Los Angeles (NARLA)
NARLA's mission is to support the development and evaluation of innovative strategies for the treatment and prevention of HIV in HIV-infected and at-risk individuals in greater Los Angeles.

Center for HIV Identification, Prevention and Treatment Services (CHIPTS)
CHIPTS, funded by the National Institute of Mental Health, leverages world class science to combat HIV globally, in partnership with communities, families, and individuals impacted by the pandemic. Strategies for integrating, promoting, and diffusing HIV detection, prevention, and care are CHIPTS' primary mission.